Abstract
Increase in life expectancy and decrease in mortality associated with a decrease in physical activity leads to population aging and the development of certain age-related pathologies such as osteoporosis and sarcopenia. These two conditions are very often linked and denominated under the same term: osteosarcopenia. There is an interconnection between muscle and bone permitted by hormonal mediators. Involvement of hormones and calciotropic proteins in osteosarcopenia involves especially vitamin D, parathyroid hormone, osteocalcin, leptin, and gonadal steroid causing changes in bone and muscle structure and function. Osteosarcopenia is a particularly deleterious condition in older persons, increasing the risk of serious health events and reducing life expectancy. Calciotropic hormonal changes would identify people at risk and influence the evolution of health status of these people.
This Chapter presents an inventory of current knowledge concerning the involvement of main calciotropic hormones in muscular and bone health of osteosarcopenic or at-risk patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abboud M, Rybchyn MS, Liu J, Ning Y, Gordon-Thomson C, Brennan-Speranza TC, Cole L, Greenfield H, Fraser DR, Mason RS (2017) The effect of parathyroid hormone on the uptake and retention of 25-hydroxyvitamin D in skeletal muscle cells. J Steroid Biochem Mol Biol 173:173–179
Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471–478
Allison SJ, Baldock PA, Herzog H (2007) The control of bone remodeling by neuropeptide Y receptors. Peptides 28:320–325
Annweiler C, Beauchet O (2009) Relationship between bone, fracture, and exercise: the key role of vitamin D. Arch Intern Med 169:163–168
Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O (2009) Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging 13:893–898
Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O (2011) Vitamine D chez la personne âgée: les 5 points à retenir. Ger Psychol Neuropsychiatr Vieil 9:259–267
Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y (2009) Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med 218:201–205
Astudillo P, Rios S, Pastenes L, Pino AM, Rodriguez JP (2008) Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. J Cell Biochem 103:1054–1065
Atalay S, Elci A, Kayadibi H, Onder CB, Aka N (2012) Diagnostic utility of osteocalcin, Undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 32:23–30
Baczynski R, Massry SG, Magott M, el-Belbessi S, Kohan R, Brautbar N (1985) Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 28:722–727
Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Investig 109:915–921
Baldock PA, Allison S, McDonald MM, Sainsbury A, Enriquez RF, Little DG, Eisman JA, Gardiner EM, Herzog H (2006) Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 21:1600–1607
Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, Stehrer B, Lin EJ, Zhang L, Enriquez RF, Wong IP, McDonald MM, During M, Pierroz DD, Slack K, Shi YC, Yulyaningsih E, Aljanova A, Little DG, Ferrari SL, Sainsbury A, Eisman JA, Herzog H (2009) Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One 4:e8415
Bandeira F, Cassibba S (2015) Hyperparathyroidism and bone health. Rheumatol Rep 17:48
Benovic JL, Bouvier M, Caron MG, Lefkowitz RJ (1988) Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu Rev Cell Biol 4:405–428
Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin N Am 39:321–331
Binkley N, Buehring B (2009) Beyond FRAX: it’s time to consider sarco-osteopenia. J Clin Densitom 12:413–416
Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stähelin HB, Dick W (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19–24
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257–2264
Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551–561
Boland R, Norman A, Ritz E, Hasselbach W (1985) Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 128:305–311
Bolland MJ, Grey A, Reid IR (2015) Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis? Climacteric 18(Suppl 2):22–31
Brighton PJ, Szekeres PG, Willars GB (2004) Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56:231–248
Bügel S (2003) Vitamin K and bone health. Proc Nutr Soc 62:839–843
Buitrago CG, Arango NS, Boland RL (2012) 1α,25(OH)2D3-dependant modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem 113:1170–1181
Buitrago C, Pardo VG, Boland R (2013) Role of VDR in 1α,25-dihydroxyvitamin D3-dependant non genomic activation of MAPKs, Src and Akt in skeletal muscle cells. J Steroid Biochem Mol Biol 136:125–130
Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT (2001) Leptin reduces ovariectomy- induced bone loss in rats. Endocrinology 142:3546–3553
Cammisotto PG, Bukowiecki LJ (2004) Role of calcium in the secretion of leptin from white adipocytes. Am J Phys Regul Integr Comp Phys 287:R1380–R1386
Cangussu LM, Nahas-Neto J, Orsatti CL, Bueloni-Dias FN, Nahas EA (2015) Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Osteoporos Int 26:2413–2421
Capiati D, Benassati S, Boland RL (2002) 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 86:128–135
Cauley JS, Greendale GA, Ruppert K et al (2015) Serum 25 hydroxyvitamin D bone mineral density amd fracture risk across the menopause. J Clin Endocrinol Metab 100:2046–2054
Ceglia L (2009) Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12:628–633
Ceglia L, Niramitmahapanya S, da Silva MM, Rivas DA, Harris SS, Bischoff-Ferrari H, Fielding RA, Dawson-Hughes B (2013) A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 98:E1927–E1935
Chen XX, Yang T (2015) Roles of leptin in bone metabolism and bone diseases. J Bone Miner Metab 33:474–485
Christodoulou S, Goula T, Ververidis A, Drosos G (2013) Vitamin D and bone disease. Biomed Res Int 2013:396541
Cirmanova V, Bayer M, Starka L, Zajickova K (2008) The effect of leptin on bone: an evolving concept of action. Physiol Res 57(Suppl 1):S143–S151
Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405–415
Crepaldi G, Maggi S (2005) Sarcopenia and osteoporosis: ahazardous duet. J Endocrinol Investig 28:66e68
De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338
de Souza Genaro P, de Medeiros PM, Szejnfeld VL, Martini LA (2015) Secondary hyperparathyroidism and its relationship with sarcopenia in elderly women. Arch Gerontol Geriatr 60:349–353
De Spiegeleer A, Beckwée D, Bautmans I, Petrovic M, Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG) (2018) Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: an umbrella review of systematic reviews and Meta-analyses. Drugs Aging 35:719–734
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, FiAT intervention group (2016) Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 28:895–899
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207
Dupuy C, Lauwers-Cances V, van Kan GA, Gillette S, Schott AM, Beauchet O, Annweiler C, Vellas B, Rolland Y (2013) Dietary vitamin D intake and muscle mass in older women. Results from a cross-sectional analysis of the EPIDOS study. J Nutr Health Aging 17:119–124
Duque G, Daly RM, Sanders K, Kiel DP (2017) Vitamin D, bones and muscle: myth versus reality. Australas J Ageing 36:8–13
Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G (2005) Leptin regulation of bone resorp- tion by the sympathetic nervous system and CART. Nature 434:514–520
Faggioni R, Feingold KR, Grunfeld C (2001) Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15:2565–2571
Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296–308
Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Svein- bjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197
Flier JS (1997) Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci U S A 94:4242–4245
Frederich RC, Löllmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS (1995) Expression of Ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96:1658–1663
Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122:803–815
Garber AJ (1983) Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J Clin Invest 71:1806–1821
Grigorie D, Neacsu E, Marinescu M, Popa O (2003) Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. Roman J Int Med 41:409–415
Gumieiro DN, Murino Rafacho BP, Buzati Pereira BL, Cavallari KA, Tanni SE, Azevedo PS, Polegato BF, Mamede Zornoff LA, Dinhane DI, Innocenti Dinhane KG, Cação Pereira GJ, de Paiva SA, Minicucci MF (2015) Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. Nutrition 31:931–934
Gundberg CM, Lian JB, Gallop PM, Steinberg JJ (1983) Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget’s disease. J Clin Endocrinol Metab 57:1221–1225
Hadji P, Bock K, Gotschalk M, Hars O, Backhus J, Emons G, Schulz KD (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 44:141–148
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546
Hamrick MW (2017) Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging. J Bone Metab 24:1–8
Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hart-zell D, Baile CA (2005) Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin- deficient ob/ob mice. J Bone Miner Res 20:994–1001
Hanada R, Teranishi H, Pearson JT, Kurokawa M, Hosoda H, Fukushima N, Fukue Y, Serino R, Fujihara H, Ueta Y, Ikawa M, Okabe M, Murakami N, Shirai M, Yoshimatsu H, Kangawa K, Kojima M (2004) Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 10:1067–1073
Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician nov 46:849–853
Hipmair G, Bohler N, Maschek W, Soriguer F, Rojo-Martinez G, Schimetta W, Pichler R (2010) Serum leptin is correlated to high turnover in osteoporosis. Neuro Endocrinol Lett 31:155–160
Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781–2790
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17:200–209
Holvik K, Ahmed LA, Forsmo S et al (2013) Low serum levels of 25-hydroxyvitamin D predict hip fracture in the elderly: a NOREPOS study. J Clin Endocrinol Metab 98:3341–3350
Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD et al (2004) PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res févr 19(2):235–244
Hubbard RE, O'Mahony MS, Calver BL, Woodhouse KW (2008) Nutrition, inflammation, and leptin levels in aging and frailty. J Am Geriatr Soc 56:279–284
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, Demontiero O, Duque G (2015a) Comprehensive nutritional status in sarco-osteoporotic older adults. J Nutr Health Aging 19:474–480
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, Gunawardene P, Demontiero O, Duque G (2015b) Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc 16:290–295
Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ (2014) Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev 15:51–60
Irani PF (1976) Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 39:686–693
Irazoqui AP, Boland RL, Buitrago CG (2014) Actions of 1,25(OH)2-vitamin D on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells. J Mol Endocrinol 53:331–343
Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Vääräniemi HK (2004) Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361–18369
Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434–1446
Joborn C, Joborn H, Rastad J (1988) Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 75:77–80
Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341–348
Karsenty G, Olson EN (2016) Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell 164:1248–1256
Kawao N, Kaji H (2015) Interactions between muscle tissues and bone metabolism. J Cell Biochem 116:687–695
Kishida Y, Hirao M, Tamai N, Nampei A, Fujimoto T, Nakase T, Shimizu N, Yoshikawa H, Myoui A (2005) Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone 37:607–621
Kristoffersson A, Boström A, Söderberg T (1992) Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 79:165–168
Kuo TR, Chen CH (2017) Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res 5:18
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469
Levinger I, Lin X, Zhang X, Brennan-Speranza TC, Volpato B, Hayes A, Jerums G, Seeman E, McConell G (2016) The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo. Osteoporos Int 27:653–663
Levy JR, Gyarmati J, Lesko JM, Adler RA, Stevens W (2000) Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway. Am J Physiol Endocrinol Metab 278:E892–E901
Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38:189–200
Lin YY, Chen CY, Ding ST (2017) Adiponectin receptor 1 resists the decline of serum osteocalcin and GPRC6A expression in ovariectomized mice. PLoS One 12:e0189063
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501
Lips P, van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25:585–591
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155–1161
Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dar-deno TA, Kim SY, Hamnvik OP, Koniaris A (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567–E584
Maor G, Rochwerger M, Segev Y, Phillip M (2002) Leptin acts as a growth factor on the chondrocytes of skeletal growth cen- ters. J Bone Miner Res 17:1034–1043
Martin A, de Vittoris R, David V, Moraes R, Begeot M, Lafage- Proust MH, Alexandre C, Vico L, Thomas T (2005) Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology 146:3652–3659
Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and risk of mortality in the general population. Arch Intern Med 168:1629–1637
Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G (2017) Osteocalcin signaling in Myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 25:218
Michos ED, Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Metab Care 11:7–12
Mitnick MA, Grey A, Masiukiewicz U, Bartkiewicz M, Rios-Velez L, Friedman S, Xu L, Horowitz MC, Insogna K (2001) Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol Endocrinol Metab 280:E405–E412
Molina P, Carrero JJ, Bover J, Chauveau P, Mazzaferro S, Torres PU, European Renal Nutrition (ERN) and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Working Groups of the European Renal Association-European Dialysis Transplant Association (ERA-EDTA) (2017) Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle 8:686–701
Montero-Odasso M, Sakurai R, Muir-Hunter S, Islam A, Doherty T, Duque G, Crilly R (2016) Serum parathyroid hormone but not vitamin D is associated with impaired gait in community-dwelling older adults. J Am Geriatr Soc 64:2606–2608
Mori A, Nishino T, Obata Y, Nakazawa M, Hirose M, Yamashita H, Uramatsu T, Shinzato K, Kohno S (2013) The effect of active vitamin D administration on muscle mass in hemodialysis patients. Clin Drug Investig 33:837–846
Motyl KJ, Rosen CJ (2012 Oct) Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie 94(10):2089–2096
Muoio DM, Dohm GL, Fiedorek FT Jr, Tapscott EB, Coleman RA (1997) Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46:1360–1363
Odabasi E, Ozata M, Turan M, Bingol N, Yonem A, Cakir B, Kutlu M, Ozdemir IC (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173
Ormarsdottir S, Ljunggren O, Mallmin H, Olofsson H, Blum WF, Loof L (2001) Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver dis- ease. J Gastroenterol Hepatol 16:1409–1414
Park S, Ham JO, Lee BK (2014) A positive association of vitamin D deficiency and sarcopenia in 50 year old women, but not men. Clin Nutr 33:900–905
Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Euro J Clin Invest 35:290–304
Pleasure D, Wyszynski B, Summer A, Schotland D, Feldman B, Nugent N, Hitz K, Goodman DB (1979) Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Invest 64:1157–1167
Prineas JW, Mason AS, Henson RA (1965) Myopathy in metabolic bone disease. Br Med J 1:1034–1036
Reid IR, Bolland MJ, Grey A (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155
Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA (2001) Leptin is ex- pressed in and secreted from primary cultures of human os- teoblasts and promotes bone mineralization. J Bone Miner Res 16:1426–1433
Roux C, Arabi A, Porcher R, Garnero P (2003) Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 33:847–852
Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17:1896–1903
Sahin G, Polat G, Baethis S, Milcan A, Baethdatoethlu O, Er-doethan C, Camdeviren H (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 3:87–91
Sáinz N, Rodríguez A, Catalán V, Becerril S, Ramírez B, Gómez-Ambrosi J, Frühbeck G (2009) Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One 4:e6808
Salles J, Chanet A, Giraudet C, Patrac V, Pierre P, Jourdan M, Luiking YC, Verlaan S, Migné C, Boirie Y, Walrand S (2013) 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes. Mol Nutr Food Res 57:2137–2146
Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Zochling J, Sitoh YY, Lau TC, Schwarz J, Seibel MJ (2004) Serum parathyroid hor- mone predicts time to fall independent of vitamin D status in a frail elderly popu- lation. J Clin Endocrinol Metab 89:1572–1576
Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Yasuda K (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86:5273–5276
Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20:187–192
Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K, Takeda S (2007) Central control of bone remodeling by neuromedin U. Nat Med 13:1234–1240
Schwetz V, Pieber T, Obermayer-Pietsch B (2012) The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol 166:959–967
Scott D, Ebeling PR, Sanders KM, Aitken D, Winzenberg T, Jones G (2015) Vitamin d and physical activity status: associations with five-year changes in body composition and muscle function in community-dwelling older adults. J Clin Endocrinol Metab 100:670–678
Shi YC, Baldock PA (2012) Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue. Bone 50:430–436
Singh S, Kumar D, Lal AK (2015) Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women. J Clin Diagn Res 9:RC04–RC07
Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980–2985
Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ (2002) Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283:E187–E192
Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Murthy L, Grill V, Duque G (2018) High parathyroid hormone levels are associated with osteosarcopenia in older individuals with a history of falling. Maturitas 113:21–25
Swaminathan R (2001) Biochemical markers of bone turnover. Clin Chim Acta 313:95–105
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271
Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638
Thomas T, Burguera B, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Riggs BL, Khosla S (2001) Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114–120
Turner RT, Kalra SP, Wong CP, Philbrick KA, Lindenmaier LB, Boghossian S, Iwaniec UT (2013) Peripheral leptin regulates bone formation. J Bone Miner Res 28:22–34
Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB et al (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332
Visser M, Deeg DJ, Lips P (2003) Longitudinal aging study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 88:5766–5772
Walrand S (2016) Effect of vitamin D on skeletal muscle. Geriatr Psychol Neuropsychiatr Vieil 14:127–134
Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L (1998) A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684–688
Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA, Bloom SR (2002) Hypothalamic actions of neuromedin U. Endocrinology 143:4227–4234
Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH (2010) Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 411:771–775
Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 55:341–347
Yasumura S, Aloia JF, Gundberg CM, Yeh J, Vaswani AN, Yuen K, Lo Monte AF, Ellis KJ, Cohn SH (1987) Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 64:681–685
Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640–1646
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Duval, G.T., Meytadier, H., Annweiler, C., Duque, G. (2019). Calciotropic Hormones and Osteosarcopenia. In: Duque, G. (eds) Osteosarcopenia: Bone, Muscle and Fat Interactions. Springer, Cham. https://doi.org/10.1007/978-3-030-25890-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-25890-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25889-4
Online ISBN: 978-3-030-25890-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)